Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer.

BMC Gastroenterol · 2025 · PMC11770934 · PMID 39871125

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

Additionally, a COX survival analysis was conducted, revealing that KRAS G12D , along with higher TNM stage, LVI, tumor deposits, and PNI, were all associated with a decrease in survival time for patients with rectal cancer; however, these factors did not reach statistical significance ( p > 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.